Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder associated with liver disease, ranging from fibrosis to ...

A month has gone by since the last earnings report for Krystal Biotech, Inc. (KRYS). Shares have added about 6.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

alpha-1 AT = alpha-1 antitrypsin; ANA = antinuclear antibodies; SMA = smooth muscle antibodies; anti-LKM1 = antibodies to liver/kidney microsome type 1; AMA = antimitochondrial antibodies ...

BNP Paribas Financial Markets raised its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 88.0% during the ...

AVG-002 is being developed by AlveoGene using its InGenuiTy® platform, which employs a unique pseudotyped lentiviral vector to deliver a functional SP-B gene directly to the neonaal deep lung alveolar ...

“A chronic cough is often the first symptom which, over time, becomes more persistent,” notes Chaggar. “As COPD progresses, ...

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve brokerages that are covering the stock, Marketbeat Ratings reports. Four ...

Atypical radiological manifestation of sarcoidosis presenting with an anterior mediastinal mass ...

After hours: 29 November at 1:02 pm GMT-5 ...